Literature DB >> 22339434

Differences in susceptibility to inactivation of human aldehyde dehydrogenases by lipid peroxidation byproducts.

Belem Yoval-Sánchez1, José S Rodríguez-Zavala.   

Abstract

Aldehyde dehydrogenases (ALDHs) are involved in the detoxification of aldehydes generated as byproducts of lipid peroxidation. In this work, it was determined that, among the three most studied human ALDH isoforms, ALDH2 showed the highest catalytic efficiency for oxidation of acrolein, 4-hydroxy-2-nonenal (4-HNE), and malondialdehyde. ALDH1A1 also exhibited significant activity with these substrates, whereas ALDH3A1 only showed activity with 4-HNE. ALDH2 was also the most sensitive isoform to irreversible inactivation by these compounds. Remarkably, ALDH3A1 was insensitive to these aldehydes even at concentrations as high as 20 mM. Formation of adducts of ALDH1A1 and ALDH2 with acrolein increased their K(d) values for NAD(+) by 2- and 3-fold, respectively. NADH exerted a higher protection than propionaldehyde to the inactivation by acrolein, and this protection was additive. These results suggested that both binding sites, those for aldehyde and NAD(+) in ALDH2, are targets for the inactivation by lipid peroxidation products. Thus, with the advantage of being relatively inactivation-insensitive, ALDH1A1 and ALDH3A1 may be actively participating in the detoxification of these aldehydes in the cells.
© 2012 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22339434     DOI: 10.1021/tx2005184

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  38 in total

Review 1.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

Review 2.  Targeting aldehyde dehydrogenase 2: new therapeutic opportunities.

Authors:  Che-Hong Chen; Julio Cesar Batista Ferreira; Eric R Gross; Daria Mochly-Rosen
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

3.  Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.

Authors:  Yuki Matsumura; Na Li; Hanan Alwaseem; Odelya E Pagovich; Ronald G Crystal; Matthew B Greenblatt; Katie M Stiles
Journal:  Hum Gene Ther       Date:  2020-01-28       Impact factor: 5.695

Review 4.  A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant.

Authors:  Eric R Gross; Vanessa O Zambelli; Bryce A Small; Julio C B Ferreira; Che-Hong Chen; Daria Mochly-Rosen
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-09-29       Impact factor: 13.820

Review 5.  Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease.

Authors:  Edna Grünblatt; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2014-10-09       Impact factor: 3.575

6.  Human ALDH1B1 polymorphisms may affect the metabolism of acetaldehyde and all-trans retinaldehyde--in vitro studies and computational modeling.

Authors:  Brian C Jackson; Philip Reigan; Bettina Miller; David C Thompson; Vasilis Vasiliou
Journal:  Pharm Res       Date:  2014-11-21       Impact factor: 4.200

7.  Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.

Authors:  Sarah K Woody; Helen Zhou; Shaher Ibrahimi; Yafeng Dong; Liqin Zhao
Journal:  J Alzheimers Dis       Date:  2016-06-18       Impact factor: 4.472

8.  Role of aldehyde dehydrogenase 2 in 1-methy-4-phenylpyridinium ion-induced aldehyde stress and cytotoxicity in PC12 cells.

Authors:  Ai-Hua Chen; Ping Zhang; Wei-Lan Yin; Li Wang; Wei Zou; Xiao-Qing Tang
Journal:  Neurochem Res       Date:  2014-07-09       Impact factor: 3.996

9.  A comparison of CRISPR/Cas9 and siRNA-mediated ALDH2 gene silencing in human cell lines.

Authors:  Fei Wang; Tao Guo; Hongmei Jiang; Ruobi Li; Ting Wang; Ni Zeng; Guanghui Dong; Xiaowen Zeng; Daochuan Li; Yongmei Xiao; Qiansheng Hu; Wen Chen; Xiumei Xing; Qing Wang
Journal:  Mol Genet Genomics       Date:  2018-01-30       Impact factor: 3.291

10.  Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking.

Authors:  Adrien Guillot; Tianyi Ren; Tony Jourdan; Robert J Pawlosky; Elaine Han; Seung-Jin Kim; Li Zhang; George F Koob; Bin Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.